ArticleTargeted oncology2019

Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer.

Y Louise Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.